Global Market Insights, Inc. - logo

Point of Care (PoC) Molecular Diagnostics Market Size By Technology [Polymerase Chain Reaction (Real Time PCR, DNA/RNA Purification), In Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others], By Infectious Diseases (MRSA, Clostridium difficile, Vancomycin-resistant Enterococci, Carbapenem-Resistant Bacteria Testing, Flu, Respiratory Syncytial Virus, Candida, Tuberculosis and Drug-resistant TB, Meningitis, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HIV , Hepatitis C, Hepatitis B, HPV, Syphilis, Others), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, South Korea, Malaysia, Thailand, Vietnam, Philippines, Australia, Brazil, Argentina, Mexico, South Africa, Nigeria, Egypt, Morocco, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024

Published Date: November 2017 | 150 Pages | Report ID: GMI2210 Report Format: PDF

Inquiry Before Buying   Request Sample

Report Content

Chapter 1    Methodology   

1.1    Methodology   

1.1.1    Initial data exploration

1.1.2    Statistical model and forecast

1.1.3    Industry insights and validation

1.1.4    Market definition and forecast parameters

1.2    Data Sources  

1.2.1    Secondary

1.2.2    Primary

Chapter 2    Executive Summary  

2.1    PoC molecular diagnostics industry 3600 synopsis, 2013 - 2024   

2.1.1    Business trends

2.1.2    Technology trends

2.1.3    Infectious disease trends

2.1.4    Regional trends

Chapter 3    PoC Molecular Diagnostics Industry Insights    

3.1    Industry segmentation

3.2    Industry landscape, 2013 – 2024    

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing incidences of infectious diseases

3.3.1.2    Increasing R&D funding to reduce time required for molecular diagnostic tests   

3.3.1.3    Growing awareness about pre-disease diagnostics to control occurrence of diseases  

3.3.1.4    Technological advancements in DNA sequencing and analysis   

3.3.2    Industry pitfalls & challenges     

3.3.2.1    Long product development time     

3.3.2.2    Complex regulatory process   

3.4    Growth potential analysis   

3.4.1    By technology

3.4.2    By infectious diseases    

3.5    Technology landscape 

3.6    All in one diagnostics solutions overview   

3.6.1    Companies operating in all in one diagnostics   

3.6.2    Major end user types

3.6.3    Industry drivers and pitfalls 

3.6.4    Pipeline analysis   

3.7    Porter’s analysis    

3.8    Competitive landscape, 2016 

3.8.1    Strategy dashboard  

3.9    PESTEL analysis     

Chapter 4    PoC Molecular Diagnostics Market, By Technology

4.1    PoC molecular diagnostics market share by technology, 2016 & 2024    

4.2    PCR (Polymerase Chain Reaction)   

4.2.1    Market size, by region, 2013-2024 (USD Million)  

4.2.2    Real time PCR

4.2.2.1    Market size, by region, 2013-2024 (USD Million)   

4.2.3    DNA/RNA purification

4.2.3.1    Market size, by region, 2013-2024 (USD Million)   

4.3    In situ hybridization   

4.3.1    Market size, by region, 2013-2024 (USD Million)  

4.4    Chips and microarrays

4.4.1    Market size, by region, 2013-2024 (USD Million)  

4.5    Mass spectrometry   

4.5.1    Market size, by region, 2013-2024 (USD Million)  

4.6    Sequencing    

4.6.1    Market size, by region, 2013-2024 (USD Million)  

4.7    Isothermal amplification   

4.7.1    Market size, by region, 2013-2024 (USD Million)  

Chapter 5   PoC Molecular Diagnostics Market, By Infectious Disease    

5.1    PoC molecular diagnostics market share by infectious disease, 2016 & 2024    

5.2    MRSA   

5.2.1    Market size, by region, 2013-2024 (USD Million)  

5.3    Clostridium difficile   

5.3.1    Market size, by region, 2013-2024 (USD Million)  

5.4    Vancomycin-resistant enterococci   

5.4.1    Market size, by region, 2013-2024 (USD Million)  

5.5    Carbapenem-resistant bacteria testing   

5.5.1    Market size, by region, 2013-2024 (USD Million)  

5.6    Flu   

5.6.1    Market size, by region, 2013-2024 (USD Million)  

5.7    Respiratory syncytial virus (RSV)    

5.7.1    Market size, by region, 2013-2024 (USD Million)  

5.8    Candida

5.8.1    Market size, by region, 2013-2024 (USD Million)  

5.9    Tuberculosis and drug-resistant TB  

5.9.1    Market size, by region, 2013-2024 (USD Million)  

5.10     Meningitis   

5.10.1    Market size, by region, 2013-2024 (USD Million)  

5.11     Gastro-intestinal panel testing     

5.11.1    Market size, by region, 2013-2024 (USD Million)  

5.12     Chlamydia   

5.12.1    Market size, by region, 2013-2024 (USD Million)  

5.13     Gonorrhea   

5.13.1    Market size, by region, 2013-2024 (USD Million)  

5.14     HIV   

5.14.1    Market size, by region, 2013-2024 (USD Million)  

5.15     Hepatitis C   

5.15.1    Market size, by region, 2013-2024 (USD Million)  

5.16     Hepatitis B   

5.16.1    Market size, by region, 2013-2024 (USD Million)  

5.17     HPV    

5.17.1    Market size, by region, 2013-2024 (USD Million)  

5.18     Syphilis 

5.18.1    Market size, by region, 2013-2024 (USD Million)  

5.19     Others  

5.19.1    Market size, by region, 2013-2024 (USD Million)  

Chapter 6   PoC Molecular Diagnostics Market, By Region

6.1    PoC molecular diagnostics market share by region, 2016 & 2024 

6.2    North America 

6.2.1    Market size, by country, 2013-2024 (USD Million)

6.2.2    Market size, by technology, 2013-2024 (USD Million)    

6.2.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.2.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.2.5    U.S.   

6.2.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.2.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.2.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.2.6    Canada    

6.2.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.2.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.2.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3    Europe 

6.3.1    Market size, by country, 2013-2024 (USD Million)

6.3.2    Market size, by technology, 2013-2024 (USD Million)    

6.3.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.3.5    Germany   

6.3.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.6    UK    

6.3.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.7    France

6.3.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.8    Spain 

6.3.8.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.8.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.8.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.9    Italy   

6.3.9.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.9.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.9.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.10    Russia

6.3.10.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.10.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.10.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4    Asia Pacific    

6.4.1    Market size, by country, 2013-2024 (USD Million)

6.4.2    Market size, by technology, 2013-2024 (USD Million)    

6.4.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.4.5    Japan 

6.4.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.6    China 

6.4.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.7    India  

6.4.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.8    South Korea  

6.4.8.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.8.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.8.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.9    Malaysia   

6.4.9.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.9.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.9.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.10    Thailand   

6.4.10.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.10.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.10.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.11    Vietnam   

6.4.11.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.11.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.11.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.12    Philippines    

6.4.12.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.12.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.12.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.13    Australia   

6.4.13.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.13.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.13.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.5    Latin America  

6.5.1    Market size, by country, 2013-2024 (USD Million)

6.5.2    Market size, by technology, 2013-2024 (USD Million)    

6.5.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.5.5    Brazil 

6.5.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.5.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.5.6    Argentina   

6.5.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.5.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.5.7    Mexico

6.5.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.5.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6    MEA    

6.6.1    Market size, by country, 2013-2024 (USD Million)

6.6.2    Market size, by technology, 2013-2024 (USD Million)    

6.6.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.6.5    South Africa  

6.6.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.6    Nigeria

6.6.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.7    Egypt 

6.6.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.8    Morocco   

6.6.8.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.8.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.8.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.9    Saudi Arabia 

6.6.9.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.9.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.9.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.10    UAE   

6.6.10.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.10.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.10.3    Market size, by infectious disease, 2013-2024 (USD Million)     

Chapter 7   Company Profiles    

7.1    Abaxis Inc.    

7.1.1    Business overview   

7.1.2    Financial data

7.1.3    Product landscape   

7.1.4    SWOT analysis    

7.2    Abbott Laboratories   

7.2.1    Business overview   

7.2.2    Financial data

7.2.3    Product landscape   

7.2.4    Strategic outlook    

7.2.5    SWOT analysis    

7.3    Bayer Corporation   

7.3.1    Business overview   

7.3.2    Financial data

7.3.3    Product landscape   

7.3.4    SWOT analysis    

7.4    BioMerieux SA 

7.4.1    Business overview   

7.4.2    Financial data

7.4.3    Product landscape   

7.4.4    Strategic outlook    

7.4.5    SWOT analysis    

7.5    Bio-Rad Laboratories, Inc.   

7.5.1    Business overview   

7.5.2    Financial data

7.5.3    Product landscape   

7.5.4    Strategic outlook    

7.5.5    SWOT analysis    

7.6    Danaher Corporation  

7.6.1    Business overview   

7.6.2    Financial data

7.6.3    Product landscape   

7.6.4    Strategic outlook    

7.6.5    SWOT analysis    

7.7    OraSure Technologies, Inc.   

7.7.1    Business overview   

7.7.2    Financial data

7.7.3    Product landscape   

7.7.4    Strategic Outlook    

7.7.5    SWOT analysis    

7.8    Roche Diagnostics   

7.8.1    Business overview   

7.8.2    Financial data

7.8.3    Product landscape   

7.8.4    Strategic outlook    

7.8.5    SWOT analysis    

7.9    Sysmex Corporation   

7.9.1    Business overview   

7.9.2    Financial data

7.9.3    Product landscape   

7.9.4    Strategic Outlook    

7.9.5    SWOT analysis    

 

Data Tables

TABLE 1.    PoC molecular diagnostics industry 3600 synopsis, 2013 – 2024    

TABLE 2.    Global PoC molecular diagnostics market, 2013 – 2024 (USD Million)    

TABLE 3.    Global PoC molecular diagnostics market, by technology, 2013 - 2024 (USD Million)    

TABLE 4.    Global PoC molecular diagnostics market, by infectious disease, 2013 – 2024 (USD Million)    

TABLE 5.    Global PoC molecular diagnostics market, by region, 2013 – 2024 (USD Million) 

TABLE 6.    Industry impact forces    

TABLE 7.    PCR (Polymerase Chain Reaction) market size, by region, 2013 – 2024 (USD Million)    

TABLE 8.    Real time PCR market size, by region, 2013 – 2024 (USD Million)    

TABLE 9.    DNA/RNA purification market size, by region, 2013 – 2024 (USD Million)    

TABLE 10.    In situ hybridization market size, by region, 2013 – 2024 (USD Million)    

TABLE 11.    Chips and microarrays market size, by region, 2013 – 2024 (USD Million) 

TABLE 12.    Mass spectrometry market size, by region, 2013 – 2024 (USD Million)    

TABLE 13.    Sequencing market size, by region, 2013 – 2024 (USD Million)    

TABLE 14.    Isothermal amplification market size, by region, 2013 – 2024 (USD Million) 

TABLE 15.    MRSA market size, by region, 2013 – 2024 (USD Million)    

TABLE 16.    Clostridium difficile market size, by region, 2013 – 2024 (USD Million)    

TABLE 17.    Vancomycin-resistant enterococci market size, by region, 2013 – 2024 (USD Million)    

TABLE 18.    Carbapenem-resistant bacteria testing market size, by region, 2013 – 2024 (USD Million)    

TABLE 19.    Flu market size, by region, 2013 – 2024 (USD Million)    

TABLE 20.    Respiratory syncytial virus (RSV) market size, by region, 2013 – 2024 (USD Million)    

TABLE 21.    Candida market size, by region, 2013 – 2024 (USD Million)    

TABLE 22.    Tuberculosis and drug-resistant TB market size, by region, 2013 – 2024 (USD Million)    

TABLE 23.    Meningitis market size, by region, 2013 – 2024 (USD Million)    

TABLE 24.    Gastro-intestinal panel testing market size, by region, 2013 – 2024 (USD Million) 

TABLE 25.    Chlamydia market size, by region, 2013 – 2024 (USD Million)    

TABLE 26.    Gonorrhea market size, by region, 2013 – 2024 (USD Million)    

TABLE 27.    HIV market size, by region, 2013 – 2024 (USD Million)    

TABLE 28.    Hepatitis C market size, by region, 2013 – 2024 (USD Million)    

TABLE 29.    Hepatitis B market size, by region, 2013 – 2024 (USD Million)    

TABLE 30.    HPV market size, by region, 2013 – 2024 (USD Million)    

TABLE 31.    Syphilis market size, by region, 2013 – 2024 (USD Million)    

TABLE 32.    Others market size, by region, 2013 – 2024 (USD Million)    

TABLE 33.    North America PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million)    

TABLE 34.    North America PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 35.    North America PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 36.    North America PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 37.    U.S. PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 38.    U.S. PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 39.    U.S. PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 40.    Canada PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 41.    Canada PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 42.    Canada PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 43.    Europe PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million)    

TABLE 44.    Europe PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 45.    Europe PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 46.    Europe PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 47.    Germany PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 48.    Germany PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 49.    Germany PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 50.    UK PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 51.    UK PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 52.    UK PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 53.    France PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 54.    France PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 55.    France PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 56.    Spain PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 57.    Spain PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 58.    Spain PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 59.    Italy PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 60.    Italy PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 61.    Italy PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 62.    Russia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 63.    Russia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 64.    Russia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 65.    Asia Pacific PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million)    

TABLE 66.    Asia Pacific PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 67.    Asia Pacific PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 68.    Asia Pacific PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 69.    Japan PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 70.    Japan PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 71.    Japan PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 72.    China PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 73.    China PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 74.    China PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 75.    India PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 76.    India PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 77.    India PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 78.    South Korea PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 79.    South Korea PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 80.    South Korea PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 81.    Malaysia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 82.    Malaysia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 83.    Malaysia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 84.    Thailand PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 85.    Thailand PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 86.    Thailand PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 87.    Vietnam PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 88.    Vietnam PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 89.    Vietnam PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 90.    Philippines PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 91.    Philippines PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 92.    Philippines PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 93.    Australia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 94.    Australia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 95.    Australia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 96.    Latin America PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million)    

TABLE 97.    Latin America PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 98.    Latin America PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 99.    Latin America PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 100.    Brazil PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 101.    Brazil PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 102.    Brazil PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 103.    Argentina PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 104.    Argentina PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 105.    Argentina PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 106.    Mexico PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 107.    Mexico PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 108.    Mexico PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 109.    MEA PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million)    

TABLE 110.    MEA PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 111.    MEA PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 112.    MEA PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 113.    South Africa PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 114.    South Africa PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 115.    South Africa PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 116.    Nigeria PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 117.    Nigeria PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 118.    Nigeria PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 119.    Egypt PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 120.    Egypt PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 121.    Egypt PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 122.    Morocco PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 123.    Morocco PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 124.    Morocco PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 125.    Saudi Arabia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 126.    Saudi Arabia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 127.    Saudi Arabia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    

TABLE 128.    UAE PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)    

TABLE 129.    UAE PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million)    

TABLE 130.    UAE PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)    
 

Charts & Figures

FIG. 1    Industry segmentation    

FIG. 2    Global PoC molecular diagnostics market, 2013 – 2024 (USD Million)    

FIG. 3    Stages of new invitro diagnostic product development    

FIG. 4    Growth potential analysis, by technology    

FIG. 5    Growth potential analysis, by infectious diseases    

FIG. 6    Potential addressable end users of all in one diagnostic solutions    

FIG. 7    Comparison of time taken in standard processing and all-in-one    

FIG. 8    All in one diagnostics, industry drivers and pitfalls    

FIG. 9    Porter’s analysis    

FIG. 10    Strategy dashboard    

FIG. 11    PESTEL analysis    

FIG. 12    PoC molecular diagnostics market share by technology, 2016 & 2024    

FIG. 13    PoC molecular diagnostics market share by infectious disease, 2016 & 2024

FIG. 14    PoC molecular diagnostics market share by region, 2016 & 2024    

 

 

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security

Tailor this report

Customize this report to suit your needs, speak to our research team to avail these benefits


Connect with our sales team